Skip to main content

Ohio State’s College of Veterinary Medicine Partners with Gigi’s for Parvovirus Research Initiative

The Ohio State University College of Veterinary Medicine (CVM), in collaboration with Gigi’s, a nonprofit organization dedicated to improving the lives of shelter dogs, recently launched the Gigi’s-Ohio State University Joint Parvovirus Research Initiative. A team from the College of Veterinary Medicine will work closely the veterinarians and staff at Gigi’s who provide direct patient care. The goal of the initiative is to accelerate research to improve treatments for dogs suffering from canine parvovirus, identify new treatment strategies to improve the health and save lives of dogs infected with canine parvovirus. 

Canine parvovirus is highly fatal without treatment, but current effective treatment options are very costly. This financial barrier prevents many dog owners and shelters from treating the disease. Other treatment options are being used, but those have not been well studied. The Gigi’s-Ohio State University Joint Parvovirus Research Initiative hopes to find new ways to address this problem because effective treatments can save most of these patients. 

Led by principal investigator Jenessa Winston, DVM, PhD, DACVIM, assistant professor, Department of Veterinary Clinical Sciences at Ohio State’s College of Veterinary Medicine, the Gigi’s-Ohio State University Joint Parvovirus Research Initiative launched January 15, 2021 and runs through January 15, 2024. 

“In collaboration with Gigi’s, we aim to establish a unique interdisciplinary canine parvovirus research hub, with to the intention to develop future canine parvovirus knowledgeable scientists and veterinarians, and execute clinically relevant research projects targeted for implementation in shelters as well as other resource limited settings,” said Winston. 

The first phase of this research consists of two stages. In stage one, investigators from the CVM and Gigi’s will create a repository of samples (blood, urine and feces) and clinical information from dogs suffering from canine parvovirus enteritis.

Stage two will focus on two clinical trials focused on addressing the efficacy and cost-effectiveness of two treatment options. First, determining the clinical efficacy and financial feasibility of fecal microbiota transplantation (FMT) as an adjunctive therapeutic option for dogs suffering from canine parvovirus enteritis in a shelter setting. The second, to determine the impact of fluid therapy delivery methods on clinical outcomes of canine parvovirus infected dogs in a shelter setting.

“This extension of our research and education partnership with OSU aims to deliver unprecedented treatment to dogs suffering from this deadly disease to save even more shelter dogs,” said Colleen Shockling, DVM, MPH, co-principal investigator, director of education, outreach and the Parvovirus Treatment Center at Gigi’s. “Gigi's provides high-quality, free, veterinary care to rural shelter dogs they wouldn’t receive otherwise.”

After completing phase one, the team would expect to launch phase two, which would expand their interdisciplinary canine parvovirus research team and continue exploratory research from stored biospecimens and a clinical database. 

“If this research initiative leads to finding effective treatment options that cost less money and require less intensive medical care, this could allow more animal shelters and pet owners to successfully treat dogs that develop canine parvovirus,” said co-principal investigator Jeanette O’Quin, DVM, MPH, DABVP, DACVPM, assistant professor, Department of Veterinary Preventive Medicine, The Ohio State College of Veterinary Medicine. 

O’Quin says her hope is that this will spark interest in other researchers to reevaluate current treatment options for this and other common diseases.

This research is made possible through the generous support of George and Tina Skestos through funding from the IHS Foundation. 

“We are so proud to partner with the Ohio State College of Veterinary Medicine in this Gigi’s-Ohio State Joint Canine Parvovirus Research Initiative. We value this multidisciplinary team-based collaborative approach helping address this all too common problem, especially in shelters and other resource-limited environments,” said George and Tina Skestos. “Our collective goals are to improve the health, wellbeing and survival of these and other dogs in shelters/humane societies and to find them loving pet parents and forever homes. No dog left behind.” 

“One of the foundational principles of the College’s BE THE MODEL™ strategic plan is advancing partnerships. This collaboration between Gigi’s and The Ohio State University College of Veterinary Medicine is a prime example of the mutual benefit of working together to address common goals,” said Rustin Moore, DVM, PhD, DACVS, dean of Ohio State’s College of Veterinary Medicine and the Ruth Stanton Chair in Veterinary Medicine. 

“Identifying and demonstrating clinical efficacy and cost-effectiveness of treatments for canine parvovirus and other diseases common in pet dogs and those in shelters is in alignment with our focus on a Spectrum of Care approach to veterinary medical education and patient care. This approach addresses the growing problem of affordability of veterinary care by providing a continuum of acceptable care that considers available evidence-based medicine, client expectations and financial limitations, thereby successfully serving an economically diverse clientele,” said Moore. 

Other co-investigators from The Ohio State University College of Veterinary Medicine include Adam Rudinsky, DVM, MS, DACVIM, assistant professor, Department of Veterinary Clinical Sciences and Jason Stull, VMD, MPVM, PhD, DACVPM, assistant professor, Department of Veterinary Preventive Medicine. 

 

 

 

Categories: 

Last updated: 

Thursday, January 28, 2021 - 10:29am

Share: